World's Best Scientists 2026 revealed!
Joseph Rubin

Joseph Rubin

D-Index & Metrics

Medicine

D-Index
74
Citations
24982
World Ranking
19316
National Ranking
9623

Joseph Rubin publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Joseph Rubin sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 208 publications — 3rd percentile

3% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Joseph Rubin D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Joseph Rubin sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 74 D-Index — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Joseph Rubin is a researcher affiliated with Mayo Clinic in the United States, specializing primarily in Medicine with a focus on endocrine and metabolic disorders as well as epidemiological studies. Their research covers clinical and translational aspects particularly related to thyroid cancer and neuroendocrine tumors.

The recent scientific contributions of Joseph Rubin include studies on the diagnosis and treatment of thyroid cancer. One notable publication is titled An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid Cancer, published in 2020 in the journal Thyroid. This study explores therapeutic options for a difficult-to-treat thyroid cancer subtype, expanding knowledge on targeted therapies.

Joseph Rubin collaborates frequently with several other researchers. Their most recurrent coauthors include:

  • Keith C. Bible
  • Michael E. Menefee
  • Chia-Chi Lin
  • Michael Millward
  • William J. Maples

The distribution of publication venues for their work appears concentrated, with the journal Thyroid hosting a notable portion of their research output.

Their main fields of study include:

  • Medicine

Within Medicine, their research has specialized subfields such as:

  • Endocrinology, Diabetes and Metabolism
  • Epidemiology

Joseph Rubin focuses on two main research topics:

  • Thyroid Cancer Diagnosis and Treatment
  • Neuroendocrine Tumor Research Advances

Best Publications

  • Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5‐fluorouracil), and high dose radiation + 5‐fluorouracil. The gastrointestinal tumor study group

    C. G. Moertel;S. Frytak;R. G. Hahn;M. J. O'Connell

  • Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue.

    Larry K. Kvols;Charles G. Moertel;Michael J. O'Connell;Allan J. Schutt

  • Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms

    Charles G. Moertel;Larry K. Kvols;Michael J. O'Connell;Joseph Rubin

  • Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival

    Thorvardur R. Halfdanarson;K. G. Rabe;J. Rubin;G. M. Petersen

  • Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.

    J A Laurie;C G Moertel;T R Fleming;H S Wieand

  • Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival.

    Juan M Sarmiento;Glenroy Heywood;Joseph Rubin;Duane M Ilstrup

  • High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison.

    Charles G. Moertel;Thomas R. Fleming;Edward T. Creagan;Joseph Rubin

  • Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial.

    Edward T. Creagan;Charles G. Moertel;Judith R. O'Fallon;Allan J. Schutt

  • Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study.

    Matthew P. Goetz;Matthew R. Callstrom;J. William Charboneau;Michael A. Farrell

  • Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study.

    Keith C Bible;Vera J Suman;Julian R Molina;Robert C Smallridge

  • A Comparison of Three Chemotherapeutic Regimens in the Treatment of Advanced Pancreatic and Gastric Carcinoma: Fluorouracil vs Fluorouracil and Doxorubicin vs Fluorouracil, Doxorubicin, and Mitomycin

    Stephen A. Cullinan;Charles G. Moertel;Thomas R. Fleming;Joseph R. Rubin

  • Intra-arterial Floxuridine vs Systemic Fluorouracil for Hepatic Metastases From Colorectal Cancer: A Randomized Trial

    J. Kirk Martin;Michael J. O'Connell;Harry S. Wieand;Robert J. Fitzgibbons

  • Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer.

    M J O'Connell;J A Laurie;M Kahn;R J Fitzgibbons

  • Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors

    Thorvardur R Halfdanarson;Joseph Rubin;Michael B Farnell;Clive S Grant

  • Octreotide Acetate Long-Acting Formulation Versus Open-Label Subcutaneous Octreotide Acetate in Malignant Carcinoid Syndrome

    Joseph Rubin;Jaffer Ajani;William Schirmer;Alan P. Venook

  • Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer.

    James N. Ingle;David L. Ahmann;Stephanie J. Green;John H. Edmonson

  • Hepatic Arterial Infusion of a Replication-selective Oncolytic Adenovirus (dl1520): Phase II Viral, Immunologic, and Clinical Endpoints

    Tony Reid;Eva Galanis;James Abbruzzese;Dan Sze

  • The management of patients with advanced carcinoid tumors and islet cell carcinomas

    Charles G. Moertel;C. Michael Johnson;Michael A. McKusick;J. Kirk Martin

  • Phase II Trial of Irinotecan in Patients With Metastatic Colorectal Carcinoma

    Henry C. Pitot;Donald B. Wender;Michael J. O'Connell;Georgene Schroeder

  • Painful Metastases Involving Bone: Feasibility of Percutaneous CT- and US-guided Radio-frequency Ablation

    Matthew R. Callstrom;J. William Charboneau;Matthew P. Goetz;Joseph Rubin

Frequent Co-Authors

Larry K. Kvols
Larry K. Kvols University of South Florida
James N. Ingle
James N. Ingle Mayo Clinic
Jeff A. Sloan
Jeff A. Sloan Mayo Clinic
Richard M. Goldberg
Richard M. Goldberg West Virginia University
Matthew P. Goetz
Matthew P. Goetz Mayo Clinic
Alex A. Adjei
Alex A. Adjei Cleveland Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering a future in medicine but want flexible and affordable educational options, a range of online health degrees and career pathways are available. Those interested in pharmacy can explore the cheapest online pharmacy school programs, making it more accessible to enter this vital healthcare field.

For those focused on the administrative side of healthcare, pursuing an online mhi (Master of Health Information Management) degree can open doors to in-demand careers managing health data and systems.

Careers such as medical billing and coding are also in high demand and can be started quickly through specialized certificate or degree programs. Find out how much does it cost to become a medical coder and choose affordable online options to start working in healthcare without years of schooling.

Lastly, for nurses looking to advance, there are cheap online fnp programs (Family Nurse Practitioner), offering a pathway to higher responsibility roles with flexible study options.

Best Scientists Citing Joseph Rubin

Trending Scientists

Recently Published Articles